Absci Corporation

ABSI · Healthcare · Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States

Absci Corporation (ABSI), in the Healthcare sector, has 6 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 6 purchases and 0 sales, 1 filed past the deadline. Filers took a median of 4 days from execution to disclosure, and the most recent trade was executed Jun 30 and filed Jul 6. The most active filer was Menelas N Pangalos with 3 filings.

Add to watchlist

Filings, ttm

6 buys · 0 sells · 1 late

Traders, ttm

4 insiders

Volume, ttmiDollar value disclosed in the window

$933K

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Jun 30

Filed Jul 6

ADViAverage daily dollar volume

$40.6M

market data

Share price · 12M

$9.12 (+239.0%)

Adjusted for splits and dividends.

Volume by month

Buys $1.3M Sells $0

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Menelas N Pangalos Director 3 filings AB

Andreas Busch Chief Innovation Officer 2 filings MS

Mary T Szela Director 1 filing FH

Frans Van Houten Director 1 filing

Recent filings

Mary T SzelaPURCHASE Director $149K
12,900 sh × $11.54
Exec Jun 30
Filed Jul 6 · 4:06 PM ET † Menelas N PangalosPURCHASE Director $201K
37,453 sh × $5.36
Exec May 13
Filed May 13 · 4:05 PM ET Andreas BuschPURCHASE Chief Innovation Officer $229K
100,000 sh × $2.29
Exec Mar 12
Filed Mar 16 · 4:17 PM ET Menelas N PangalosPURCHASE Director $206K
75,095 sh × $2.74
Exec Feb 27
Filed Mar 3 · 4:13 PM ET Frans Van HoutenPURCHASE Director $149K
40,000 sh × $3.72
Exec Dec 5 2025
Filed Dec 9 2025 · 4:04 PM ET Menelas N PangalosPURCHASE Director $255K
95,785 sh × $2.66
Exec Sep 22 2025
Filed Sep 24 2025 · 4:03 PM ET Andreas BuschPURCHASE Chief Innovation Officer $152K
50,000 sh × $3.04
Exec Jul 28 2025
Filed Jul 29 2025 · 8:37 AM ET